NCT01363466终止3 期
Randomized Phase III Trial Evaluating the Impact of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
适应症
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
- UNICANCER
- 入组人数
- 61
- 试验地点
- 35
- 主要终点
- Relapse free survival
研究概览
简要总结
GYNECO 02 hypothesis is that hysterectomy reduces the possibility of local or loco-regional relapse, especially in patient with a reduced metastatic risk and who received a local chemoradiation therapy with an increase of radiotherapy doses (45 grays).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •operable Stage IB2/II Cervical Cancer
- •adenocarcinoma, squamous cell or adenosquamous carcinoma
- •Patient between 18 and 70 years old
- •No lombo-aortic lymph node invasion at baseline
- •Previous 45 grays external pelvic radiation with concomitant chemotherapy (cisplatin 40 mg/m2/week corresponding to 5 cycles)
- •Followed by a 15 grays utero-vaginal brachytherapy, eventually combined with a 6th cycle of chemotherapy (cisplatin 40 mg/m2)
- •with a pelvic boost if lymph node or parametrial invasion
- •No macroscopic residual tumor after 6 to 8 weeks after brachytherapy.
排除标准
- •Other tumor histology (neuro-endocrine)
- •Stage > II (FIGO 1995) at baseline
- •Patient with remaining cervical cancer (after sub-total hysterectomy)
研究组 & 干预措施
with hysterectomy
Experimental
干预措施: hysterectomy (Procedure)
without hysterectomy
No Intervention
结局指标
主要结局
Relapse free survival
时间窗: from randomization to relapse or last contact (up to 3 years)
There is a follow-up period of 3 years.
次要结局
- Overall Survival(From randomisation to death or last contact (up to 3 years))
研究者
研究点 (35)
Loading locations...
相似试验
已完成
3 期
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal CancerEndometrial CancerInfectionPerioperative/Postoperative ComplicationsVaginal CancerCervical CancerNCT00003267European Organisation for Research and Treatment of Cancer - EORTC214
已完成
4 期
EXPAREL for Minimally Invasive Supracervical HysterectomiesPainNCT03769714Maimonides Medical Center60
已完成
不适用
erve-sparing radical hysterectomy and local control of cervical canceruterine cervical cancerJPRN-UMIN000038866Hokkaido University Graduate School of Medicine121
已完成
不适用
Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical CancerCervical CancerNCT01658930Canadian Cancer Trials Group700
终止
不适用
Study Evaluating the Success Rate of Outpatient Management of the Total Benign Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Compared to Each of the Two Laparoscopic Routes (Conventional and Robot-assisted).SurgeryGynecologic DiseaseNCT06471049Elsan1